BELVIN MARCIA
SEC CIK 1970752 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | SVP, CSO | 300.8K | — | $294.1K | 16 | 2023-03-22 | 2026-03-17 |
Most active insiders at CTMX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McCarthy Sean A. | CEO, Dir | — | $1.23M |
| 2 | BELVIN MARCIA | SVP, CSO | — | $202.2K |
| 3 | Chu Yu-Waye | Chief Medical Off | — | $136.6K |
| 4 | Ogden Christopher | CFO | — | $129.0K |
| 5 | Lester Rachael | Chief Business Off | — | — |
| 6 | Carvajal Alejandra | CLO | — | — |
Transactions 16
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-19 | 2026-03-17 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | S - Sale | $6.42 | -31.5K | 300.8K | -9% | -$202.2K | |
| D | 2026-02-04 | 2026-02-02 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | A - Grant | $0.00 | +60.0K | 332.3K | +22% | $0 |
| D | 2025-06-17 | 2025-06-13 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | M - OptEx | $0.00 | +37.5K | 286.1K | +15% | $0 |
| D | 2025-06-17 | 2025-06-16 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | S - Sale+OE | $2.69 | -13.9K | 272.3K | -5% | -$37.3K |
| 2025-03-20 | 2025-03-18 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | S - Sale | $0.6 | -19.5K | 248.6K | -7% | -$11.7K | |
| DMA | 2025-02-10 | 2025-02-04 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | A - Grant | $0.00 | +92.5K | 210.6K | +78% | $0 |
| DM | 2025-02-06 | 2025-02-04 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | A - Grant | $0.00 | +87.5K | 263.1K | +50% | $0 |
| D | 2024-08-22 | 2024-08-20 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | M - OptEx | $0.00 | +11.2K | 179.8K | +7% | $0 |
| D | 2024-08-22 | 2024-08-20 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | S - Sale+OE | $1.23 | -4,181 | 175.6K | -2% | -$5,143 |
| 2024-03-21 | 2024-03-19 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | S - Sale | $2.09 | -12.8K | 168.6K | -7% | -$26.7K | |
| D | 2024-01-19 | 2024-01-18 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | A - Grant | $0.00 | +26.2K | 181.4K | +17% | $0 |
| 2023-12-22 | 2023-12-20 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | S - Sale | $1.38 | -4,077 | 155.1K | -3% | -$5,626 | |
| D | 2023-12-19 | 2023-12-17 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | M - OptEx | $0.00 | +11.2K | 159.2K | +8% | $0 |
| 2023-09-22 | 2023-09-22 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | S - Sale | $1.30 | -4,119 | 148.0K | -3% | -$5,355 | |
| 2023-09-22 | 2023-09-20 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | A - Grant | $0.00 | +11.2K | 152.1K | +8% | $0 | |
| 2023-03-29 | 2023-03-22 | CTMX | CytomX Therapeutics, Inc. | BELVIN MARCIA | SVP, CSO | A - Grant | $0.00 | +60.0K | 140.8K | +74% | $0 |
Purchase Sale Sale after option exercise All abbreviations